YOLFTbeta
Sedana Medical AB

Sedana Medical AB

SEDANA · ST · Healthcare / Medical Devices

9.14SEK+0.14 (+1.56%)

Price History

Full chart

Market Stats

Previous Close9.00
Open9.11
Day Range9.00 – 9.20
52-Week Range7.90 – 13.92
Volume54.64K
Market Cap955.62M
P/E (TTM)0.00
Forward P/E500.00
EPS-0.35
Dividend Yield0.00%
Beta0.87
50-Day Avg10.61
200-Day Avg9.68

About

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Johannes Doll
  • Employees117
  • HeadquartersSvärdvägen 3A, Danderyd, Sweden, 182 33, Sweden
  • Websitehttps://sedanamedical.com

Leadership

  • Mr. Johannes DollGroup CEO & President · b. 1981
  • Mr. Mikael HaagChief Financial Officer · b. 1975
  • Mr. David BergstromVice President of Operations, Supply and R&D · b. 1969
  • Ms. Karolina Vilval L.L.M.General Counsel · b. 1979
  • Ms. Sinead Renouf-WoodVice President of Marketing · b. 1986
  • Ms. Karolin SjostenVice President of Human Resources · b. 1979
  • Mr. Peter Sackey M.D., Ph.D.Chief Medical Officer · b. 1971
  • Ms. Linda FrölénHead of Group Finance · b. 1977
  • Anders ErssonHead of International Markets · b. 1969
  • Mr. Stefan KrischSupply Chain & Manufacturing Director · b. 1974

Financials

Income Statement

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue28.11M32.16M40.43M57.90M71.65M141.77M159.15M122.86M153.87M178.75M200.23M
Growth (%)-+14.38%+25.73%+43.21%+23.75%+97.88%+12.26%-22.80%+25.23%+16.17%+12.01%
Cost of Revenue10.26M9.23M9.48M15.00M19.23M52.87M52.45M36.79M44.89M52.61M57.52M
Gross Profit17.85M22.93M30.95M42.90M52.41M88.90M106.71M86.07M108.98M126.14M142.71M
Gross Margin63.49%71.30%76.56%74.09%73.16%62.71%67.05%70.06%70.83%70.57%71.27%
Operating Expense19.24M22.31M34.44M51.13M69.14M110.44M167.90M191.96M174.53M176.91M174.87M
Operating Income-1.39M618.00K-3.49M-8.24M-16.73M-21.54M-61.20M-105.89M-65.55M-50.77M-32.16M
Operating Margin-4.93%1.92%-8.63%-14.23%-23.35%-15.19%-38.45%-86.18%-42.60%-28.40%-16.06%
EBITDA163.00K1.60M-12.50K-2.87M-13.07M-17.22M-48.80M-64.87M-51.67M-4.03M-10.12M
EBITDA Margin0.58%4.99%-0.03%-4.96%-18.25%-12.15%-30.67%-52.80%-33.58%-2.26%-5.05%
Net Income-1.21M1.29M-3.88M-6.87M-16.36M-27.14M-57.97M-73.51M-59.61M-10.67M-59.24M
Net Income Margin-4.29%4.00%-9.59%-11.86%-22.83%-19.14%-36.42%-59.83%-38.74%-5.97%-29.59%
R&D--281.60K362.00K7.35M7.86M19.70M19.94M20.80M20.29M20.62M
R&D as % of Total Revenue--0.70%0.63%10.25%5.54%12.38%16.23%13.52%11.35%10.30%
Interest Expense1.14M2.02M1.84M4.10K7.00K189.00K243.00K255.00K215.00K178.00K1.45M
Interest Expense % of Total Revenue4.07%6.28%4.54%0.01%0.01%0.13%0.15%0.21%0.14%0.10%0.73%

Balance Sheet

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.40M22.90M131.38M231.55M593.25M600.10M1.17B1.08B1.01B1.02B954.46M
Total Liabilities11.95M21.64M14.97M13.74M23.87M49.00M66.12M52.43M44.06M61.17M53.68M
Total Equity448.00K1.26M116.40M217.81M569.38M551.09M1.10B1.03B970.00M958.26M900.78M
Cash3.17M8.30M85.32M159.35M464.56M376.17M836.18M607.74M231.18M193.96M90.98M
Total Debt5.71M4.92M3.60K-2.54M8.29M8.87M8.74M4.31M5.92M4.70M
Net Debt2.54M-3.38M-85.32M-159.35M-462.02M-367.88M-827.31M-599.00M-226.87M-188.04M-86.28M

Cash Flow

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-238.00K495.60K-5.78M-8.70M-7.85M-41.22M-115.43M-38.06M-11.77M-12.78M
Investing Cash Flow--5.58M-25.88M-29.13M-54.13M-84.62M-110.25M-137.78M-321.96M-44.67M-63.03M
Financing Cash Flow-10.35M102.34M108.77M368.04M5.79M605.07M-1.51M-4.86M-3.57M-4.04M
Capital Expenditure04.93M25.88M29.13M54.13M84.62M110.25M137.78M168.89M175.00M62.41M
Free Cash Flow--4.69M-25.39M-34.91M-62.83M-92.47M-151.48M-253.22M-206.95M-186.77M-75.19M
Dividends Paid-------4.61M---
FCF to OCF--1970.59%-5122.36%604.02%722.19%1178.50%367.47%219.36%543.73%1586.99%588.39%
Dividend Paid to FCF--------1.82%---

Earnings

Report DateAug 31, 2017Nov 30, 2017Mar 27, 2018May 22, 2018Aug 30, 2018Nov 22, 2018Mar 12, 2019May 8, 2019Aug 22, 2019Nov 13, 2019Mar 5, 2020May 7, 2020Aug 25, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 19, 2021Nov 4, 2021Feb 17, 2022Apr 28, 2022Jul 21, 2022Oct 25, 2022Feb 16, 2023Apr 27, 2023Jul 21, 2023Oct 26, 2023Feb 15, 2024Apr 25, 2024Jul 23, 2024Oct 24, 2024Feb 13, 2025May 6, 2025Jul 18, 2025Oct 24, 2025Feb 12, 2026Apr 23, 2026Jul 16, 2026Oct 22, 2026
EPS Estimate--0.03-0.04-0.22-0.11-0.07-0.24-0.05-0.06-0.07-0.090.040.01-0.06-0.02-0.02-0.17-0.24-0.24-0.26-0.24-0.29-0.15-0.22-0.03-0.20-0.15-0.12-0.13-0.18-0.10-0.06-0.17-0.13-0.09-0.06-0.10-0.10
EPS Actual-0.01-0.04-0.00-0.01-0.01-0.03-0.17-0.04-0.02-0.06-0.050.02-0.04-0.14-0.12-0.10-0.13-0.17-0.18-0.19-0.11-0.08-0.36-0.160.01-0.07-0.380.21-0.18-0.220.10-0.24-0.13-0.12-0.10-0.04-0.10-
Surprise--33.33%99.50%97.68%90.91%57.14%29.17%20.00%66.67%14.29%44.44%-50.00%-500.00%-133.33%-500.00%-400.00%23.53%29.17%25.00%26.92%54.17%72.41%-140.00%27.27%133.33%65.00%-153.33%275.00%-38.46%-22.22%200.00%-300.00%23.53%7.69%-11.11%33.33%0.00%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap955.62M
Enterprise Value943.93M
Trailing P/E0.00
Forward P/E500.00
Price / Sales4.89
Price / Book1.11
EPS-0.35
Book Value8.94
Revenue (TTM)195.46M
Gross Profit (TTM)140.69M
EBITDA-26.66M
Profit Margin-18.33%
Operating Margin-20.49%
Return on Equity-3.96%
Return on Assets-2.15%
Shares Outstanding99.34M
Shares Float61.93M
Beta0.87
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 26, 20214:1